Prevalence and Clinical Relevance of Occult Hepatitis B Virus Infection in Patients on the Waiting List for Kidney Transplantation

Transplantation Proceedings

Volumn 41, Issue 4, 2009, Pages 1132-1137

  Stratta, P ^a   Bruschetta, E ^a   Minisini, R ^a   Barbe M C ^a   Cornella, C ^a   Tognarelli, G ^b   Cena, T ^a   Magnani, C ^a   Fenoglio, R ^a   Toffolo, K ^a   Airoldi, A ^a   Pirisi, M ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA; HEPATITIS B SURFACE ANTIBODY; RHESUS C ANTIBODY; STEROID; VIRUS DNA;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; BLOOD SAMPLING; CAUCASIAN; CHRONIC GLOMERULONEPHRITIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA SEQUENCE; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; ITALY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SEROLOGY; VIRUS REPLICATION; BLOOD; CLINICAL TRIAL; GENETICS; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY;

DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; ITALY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; WAITING LISTS;

EID: 65549104195     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.001     Document Type: Article

References (47)

1. Lee D.S., Huh K., Lee E.H., et al. HCV and HBV coexist in HBsAg- negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area. J Gastroenterol Hepatol 12 (1997) 855
2. Mason A.L., Xu L., Guo L., et al. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 27 (1998) 1736
3. Cabrerizo M., Bartolome J., Caramelo C., et al. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 32 (2000) 116
4. Kazemi-Shirazi L., Petermann D., and Muller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C patients. J Hepatol 33 (2000) 785
5. Murakami Y., Minami M., Daimon Y., et al. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. J Med Virol 72 (2004) 203
6. Blum H.E., Galun E., Liang T.J., et al. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 65 (1991) 1836
7. Penna A., Artini M., Cavalli A., et al. Long-lasting memory T cell responses following self- limited acute hepatitis B. J Clin Invest 98 (1996) 1185
8. Carman W.F., Van Deursen F.J., Mimms L.T., et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26 (1997) 1658
9. Cacciola I., Pollicino T., Squadrito G., et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341 (1999) 22
10. Murakami Y., Minami M., Daimon Y., et al. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. J Med Virol 72 (2004) 203
11. Pollicino T., Raffa G., Costantino L., et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45 (2007) 277
12. Marusawa H., Uemoto S., Hijikata M., et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31 (2000) 488
13. Hu K.Q. Occult hepatitis B virus infection and its clinical implications. J Viral Hepatitis 9 (2002) 243
14. Brechot C., Thiers V., Kremsdorf D., et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?. Hepatology 34 (2001) 194
15. Chemin I., and Trepo C. Clinical impact of occult HBV infections. J Clin Virol 34 (2005) S15
16. Mariscal L.F., Rodriguez-Inigo E., Bartolome J., et al. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum. J Med Virol 73 (2004) 177
17. Raimondo G., Pollicino T., Cacciola I., et al. Occult hepatitis B infection. J Hepatol 46 (2007) 160
18. Raimondo G., Navarra G., Mondello S., et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 48 (2008) 743
19. Fukuda R., Ishimura N., Niigaki M., et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 54 (1998) 249
20. Hasegawa I., Orito E., Tanaka Y., et al. Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C. Liver Int 25 (2005) 247
21. Squadrito G., Pollicino T., Cacciola I., et al. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer 106 (2006) 1326
22. Chen Y.C., Shee S., Chu C.M., et al. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 123 (2002) 1084
23. Larsen J., Hetland G., and Skraug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 30 (1990) 431
24. Allain J.P. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86 (2004) 83
25. Chazouillères O., Mamish D., Kim M., et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 343 (1994) 142
26. Roche B., Samuel D., Gigou M., et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 26 (1997) 517
27. Ghisetti V., Marzano A., Zamboni F., et al. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance. Liver Transpl 10 (2004) 356
28. De Feo T.M., Poli F., Mozzi F., et al. Risk of transmission of hepatitis B virus from anti-HBc positive cadaveric organ donors: a collaborative study. Transplant Proc 37 (2005) 1238
29. Strasser S.I., and McDonald G.B. Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management. Blood 93 (1999) 1127
30. Ko W.J., Chou N.K., Hsu R.B., et al. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area. J Heart Lung Transplant 20 (2001) 865
31. Carpenter P.A., Huang M.L., and McDonald G.B. Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale. Blood 99 (2002) 4245
32. Marcellin P., Giostra E., Martinot-Peignoux M., et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 100 (1991) 1432
33. Berger A., Preiser W., Kachel H.G., et al. HBV reactivation after kidney transplantation. J Clin Virol 32 (2005) 162
34. Mathurin P., Mouquet C., Poynard T., et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29 (1999) 257
35. Behzad-Behbahani A., Mojiri A., Tabei S.Z., et al. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Transplant Proc 37 (2005) 3045
36. Yuan C.H., Liu Y.F., and Li G.C. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation. Chin Med Sci J 20 (2005) 129
37. Fabrizi F., Martin P., Dixit V., et al. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 5 (2005) 2913
38. Peres A.A., Dias E.A., Chesky M., et al. Occult hepatitis B in renal transplant patients. Transpl Infect Dis 7 (2005) 51
39. Pollicino T., Squadrito G., Cerenzia G., et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126 (2004) 102
40. Besisik F., Karaca C., Akyüz F., et al. Occult HBV infection and YMDD variants in haemodialysis patient with chronic HCV infection. J Hepatol 38 (2003) 506
41. Minuk G.Y., Sun D.F., Greenberg R., et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 40 (2004) 1072
42. Fabrizi F., Messa P.G., Lunghi G., et al. Occult hepatitis B virus infection in dialisi patients: a multi center survey. Aliment Pharmacol Ther 21 (2005) 1341
43. Siagris D., Christofidou M., Triga K., et al. Occult hepatitis B virus infection in hemodialysis patient with chronic HCV infection. J Nephrol 19 (2006) 327
44. Kanbay M., Gur G., Akcay A., et al. Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients?. Dig Dis Sci 51 (2006) 1962
45. Goral V., Ozkul H., Tekes S., et al. Prevalence of occult HBV infection in haemodialysis patients with chronic HCV. World J Gastroenterol 12 (2006) 3420
46. Fung S.K., Chae H.B., Fontana R.J., et al. Virological response and resistance to adefovir in patients with chronic hepatitis. J Hepatol 44 (2006) 283
47. Raimondo G., Allain J.P., Zanetti A.R., et al. Statements for the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49 (2008) 652